カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

医薬品用CBDオイルの世界市場2022：フルスペクトラムCBDオイル、ブロードスペクトラムCBDオイル

◆英語タイトル：Global Pharmaceutical Grade CBD Oil Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22NO19536 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年11月（※2025年版があります。お問い合わせください。） ◆ページ数：117 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

医薬品用CBDオイル市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の医薬品用CBDオイルの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

医薬品用CBDオイル市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・フルスペクトラムCBDオイル、ブロードスペクトラムCBDオイル

用途別セグメントは次のように区分されます。
・不安神経症、線維筋痛症、糖尿病、その他

世界の医薬品用CBDオイル市場の主要な市場プレーヤーは以下のとおりです。
・Kazmira、Charlotte's Web、GL Brands, Inc.、Green Road、Medical Marijuana, Inc.、Folium Biosciences、HempLife Today、Cannavest、PHARM-CBD, LLC、ENDOCA、CBD American Shaman、NuLeaf Naturals、K.I.N.D. Concentrates、Canopy Growth Corporation、Aphria、Emblem Cannabis Oils、Whistler、The Lab、Absolute Terps

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、医薬品用CBDオイル製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な医薬品用CBDオイルメーカーの企業概要、2019年～2022年までの医薬品用CBDオイルの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な医薬品用CBDオイルメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別医薬品用CBDオイルの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの医薬品用CBDオイルの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での医薬品用CBDオイル市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および医薬品用CBDオイルの産業チェーンを掲載しています。
・第13、14、15章では、医薬品用CBDオイルの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 医薬品用CBDオイルの概要
- 種類別分析（2017年vs2021年vs2028年）：フルスペクトラムCBDオイル、ブロードスペクトラムCBDオイル
- 用途別分析（2017年vs2021年vs2028年）：不安神経症、線維筋痛症、糖尿病、その他
- 世界の医薬品用CBDオイル市場規模・予測
- 世界の医薬品用CBDオイル生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Kazmira、Charlotte's Web、GL Brands, Inc.、Green Road、Medical Marijuana, Inc.、Folium Biosciences、HempLife Today、Cannavest、PHARM-CBD, LLC、ENDOCA、CBD American Shaman、NuLeaf Naturals、K.I.N.D. Concentrates、Canopy Growth Corporation、Aphria、Emblem Cannabis Oils、Whistler、The Lab、Absolute Terps
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：フルスペクトラムCBDオイル、ブロードスペクトラムCBDオイル
・用途別分析2017年-2028年：不安神経症、線維筋痛症、糖尿病、その他
・医薬品用CBDオイルの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・医薬品用CBDオイルのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・医薬品用CBDオイルのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・医薬品用CBDオイルの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・医薬品用CBDオイルの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Pharmaceutical Grade CBD Oil market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pharmaceutical Grade CBD Oil market size is estimated to be worth US$ 309.7 million in 2021 and is forecast to a readjusted size of USD 1631.9 million by 2028 with a CAGR of 26.8% during review period. Anxiety accounting for % of the Pharmaceutical Grade CBD Oil global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Full Spectrum CBD Oil segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pharmaceutical Grade CBD Oil include Kazmira, Charlotte’s Web, GL Brands, Inc., Green Road, and Medical Marijuana, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pharmaceutical Grade CBD Oil market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Full Spectrum CBD Oil
Broad Spectrum CBD Oil
Market segment by Application can be divided into
Anxiety
Fibromyalgia
Diabetes
Others
The key market players for global Pharmaceutical Grade CBD Oil market are listed below:
Kazmira
Charlotte’s Web
GL Brands, Inc.
Green Road
Medical Marijuana, Inc.
Folium Biosciences
HempLife Today
Cannavest
PHARM-CBD, LLC
ENDOCA
CBD American Shaman
NuLeaf Naturals
K.I.N.D. Concentrates
Canopy Growth Corporation
Aphria
Emblem Cannabis Oils
Whistler
The Lab
Absolute Terps
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceutical Grade CBD Oil product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pharmaceutical Grade CBD Oil, with price, sales, revenue and global market share of Pharmaceutical Grade CBD Oil from 2019 to 2022.
Chapter 3, the Pharmaceutical Grade CBD Oil competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Grade CBD Oil breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pharmaceutical Grade CBD Oil market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical Grade CBD Oil.
Chapter 13, 14, and 15, to describe Pharmaceutical Grade CBD Oil sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Pharmaceutical Grade CBD Oil Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pharmaceutical Grade CBD Oil Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Full Spectrum CBD Oil
1.2.3 Broad Spectrum CBD Oil
1.3 Market Analysis by Application
1.3.1 Overview: Global Pharmaceutical Grade CBD Oil Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Anxiety
1.3.3 Fibromyalgia
1.3.4 Diabetes
1.3.5 Others
1.4 Global Pharmaceutical Grade CBD Oil Market Size & Forecast
1.4.1 Global Pharmaceutical Grade CBD Oil Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Pharmaceutical Grade CBD Oil Sales in Volume (2017-2028)
1.4.3 Global Pharmaceutical Grade CBD Oil Price (2017-2028)
1.5 Global Pharmaceutical Grade CBD Oil Production Capacity Analysis
1.5.1 Global Pharmaceutical Grade CBD Oil Total Production Capacity (2017-2028)
1.5.2 Global Pharmaceutical Grade CBD Oil Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pharmaceutical Grade CBD Oil Market Drivers
1.6.2 Pharmaceutical Grade CBD Oil Market Restraints
1.6.3 Pharmaceutical Grade CBD Oil Trends Analysis
2 Manufacturers Profiles
2.1 Kazmira
2.1.1 Kazmira Details
2.1.2 Kazmira Major Business
2.1.3 Kazmira Pharmaceutical Grade CBD Oil Product and Services
2.1.4 Kazmira Pharmaceutical Grade CBD Oil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Charlotte’s Web
2.2.1 Charlotte’s Web Details
2.2.2 Charlotte’s Web Major Business
2.2.3 Charlotte’s Web Pharmaceutical Grade CBD Oil Product and Services
2.2.4 Charlotte’s Web Pharmaceutical Grade CBD Oil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GL Brands, Inc.
2.3.1 GL Brands, Inc. Details
2.3.2 GL Brands, Inc. Major Business
2.3.3 GL Brands, Inc. Pharmaceutical Grade CBD Oil Product and Services
2.3.4 GL Brands, Inc. Pharmaceutical Grade CBD Oil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Green Road
2.4.1 Green Road Details
2.4.2 Green Road Major Business
2.4.3 Green Road Pharmaceutical Grade CBD Oil Product and Services
2.4.4 Green Road Pharmaceutical Grade CBD Oil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Medical Marijuana, Inc.
2.5.1 Medical Marijuana, Inc. Details
2.5.2 Medical Marijuana, Inc. Major Business
2.5.3 Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Product and Services
2.5.4 Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Folium Biosciences
2.6.1 Folium Biosciences Details
2.6.2 Folium Biosciences Major Business
2.6.3 Folium Biosciences Pharmaceutical Grade CBD Oil Product and Services
2.6.4 Folium Biosciences Pharmaceutical Grade CBD Oil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 HempLife Today
2.7.1 HempLife Today Details
2.7.2 HempLife Today Major Business
2.7.3 HempLife Today Pharmaceutical Grade CBD Oil Product and Services
2.7.4 HempLife Today Pharmaceutical Grade CBD Oil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Cannavest
2.8.1 Cannavest Details
2.8.2 Cannavest Major Business
2.8.3 Cannavest Pharmaceutical Grade CBD Oil Product and Services
2.8.4 Cannavest Pharmaceutical Grade CBD Oil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 PHARM-CBD, LLC
2.9.1 PHARM-CBD, LLC Details
2.9.2 PHARM-CBD, LLC Major Business
2.9.3 PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Product and Services
2.9.4 PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 ENDOCA
2.10.1 ENDOCA Details
2.10.2 ENDOCA Major Business
2.10.3 ENDOCA Pharmaceutical Grade CBD Oil Product and Services
2.10.4 ENDOCA Pharmaceutical Grade CBD Oil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 CBD American Shaman
2.11.1 CBD American Shaman Details
2.11.2 CBD American Shaman Major Business
2.11.3 CBD American Shaman Pharmaceutical Grade CBD Oil Product and Services
2.11.4 CBD American Shaman Pharmaceutical Grade CBD Oil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 NuLeaf Naturals
2.12.1 NuLeaf Naturals Details
2.12.2 NuLeaf Naturals Major Business
2.12.3 NuLeaf Naturals Pharmaceutical Grade CBD Oil Product and Services
2.12.4 NuLeaf Naturals Pharmaceutical Grade CBD Oil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 K.I.N.D. Concentrates
2.13.1 K.I.N.D. Concentrates Details
2.13.2 K.I.N.D. Concentrates Major Business
2.13.3 K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Product and Services
2.13.4 K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Canopy Growth Corporation
2.14.1 Canopy Growth Corporation Details
2.14.2 Canopy Growth Corporation Major Business
2.14.3 Canopy Growth Corporation Pharmaceutical Grade CBD Oil Product and Services
2.14.4 Canopy Growth Corporation Pharmaceutical Grade CBD Oil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Aphria
2.15.1 Aphria Details
2.15.2 Aphria Major Business
2.15.3 Aphria Pharmaceutical Grade CBD Oil Product and Services
2.15.4 Aphria Pharmaceutical Grade CBD Oil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Emblem Cannabis Oils
2.16.1 Emblem Cannabis Oils Details
2.16.2 Emblem Cannabis Oils Major Business
2.16.3 Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Product and Services
2.16.4 Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Whistler
2.17.1 Whistler Details
2.17.2 Whistler Major Business
2.17.3 Whistler Pharmaceutical Grade CBD Oil Product and Services
2.17.4 Whistler Pharmaceutical Grade CBD Oil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 The Lab
2.18.1 The Lab Details
2.18.2 The Lab Major Business
2.18.3 The Lab Pharmaceutical Grade CBD Oil Product and Services
2.18.4 The Lab Pharmaceutical Grade CBD Oil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Absolute Terps
2.19.1 Absolute Terps Details
2.19.2 Absolute Terps Major Business
2.19.3 Absolute Terps Pharmaceutical Grade CBD Oil Product and Services
2.19.4 Absolute Terps Pharmaceutical Grade CBD Oil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pharmaceutical Grade CBD Oil Breakdown Data by Manufacturer
3.1 Global Pharmaceutical Grade CBD Oil Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Pharmaceutical Grade CBD Oil Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Pharmaceutical Grade CBD Oil
3.4 Market Concentration Rate
3.4.1 Top 3 Pharmaceutical Grade CBD Oil Manufacturer Market Share in 2021
3.4.2 Top 6 Pharmaceutical Grade CBD Oil Manufacturer Market Share in 2021
3.5 Global Pharmaceutical Grade CBD Oil Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Pharmaceutical Grade CBD Oil Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pharmaceutical Grade CBD Oil Market Size by Region
4.1.1 Global Pharmaceutical Grade CBD Oil Sales in Volume by Region (2017-2028)
4.1.2 Global Pharmaceutical Grade CBD Oil Revenue by Region (2017-2028)
4.2 North America Pharmaceutical Grade CBD Oil Revenue (2017-2028)
4.3 Europe Pharmaceutical Grade CBD Oil Revenue (2017-2028)
4.4 Asia-Pacific Pharmaceutical Grade CBD Oil Revenue (2017-2028)
4.5 South America Pharmaceutical Grade CBD Oil Revenue (2017-2028)
4.6 Middle East and Africa Pharmaceutical Grade CBD Oil Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Pharmaceutical Grade CBD Oil Sales in Volume by Type (2017-2028)
5.2 Global Pharmaceutical Grade CBD Oil Revenue by Type (2017-2028)
5.3 Global Pharmaceutical Grade CBD Oil Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Pharmaceutical Grade CBD Oil Sales in Volume by Application (2017-2028)
6.2 Global Pharmaceutical Grade CBD Oil Revenue by Application (2017-2028)
6.3 Global Pharmaceutical Grade CBD Oil Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Pharmaceutical Grade CBD Oil Sales by Type (2017-2028)
7.2 North America Pharmaceutical Grade CBD Oil Sales by Application (2017-2028)
7.3 North America Pharmaceutical Grade CBD Oil Market Size by Country
7.3.1 North America Pharmaceutical Grade CBD Oil Sales in Volume by Country (2017-2028)
7.3.2 North America Pharmaceutical Grade CBD Oil Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Pharmaceutical Grade CBD Oil Sales by Type (2017-2028)
8.2 Europe Pharmaceutical Grade CBD Oil Sales by Application (2017-2028)
8.3 Europe Pharmaceutical Grade CBD Oil Market Size by Country
8.3.1 Europe Pharmaceutical Grade CBD Oil Sales in Volume by Country (2017-2028)
8.3.2 Europe Pharmaceutical Grade CBD Oil Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Pharmaceutical Grade CBD Oil Sales by Type (2017-2028)
9.2 Asia-Pacific Pharmaceutical Grade CBD Oil Sales by Application (2017-2028)
9.3 Asia-Pacific Pharmaceutical Grade CBD Oil Market Size by Region
9.3.1 Asia-Pacific Pharmaceutical Grade CBD Oil Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Pharmaceutical Grade CBD Oil Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Pharmaceutical Grade CBD Oil Sales by Type (2017-2028)
10.2 South America Pharmaceutical Grade CBD Oil Sales by Application (2017-2028)
10.3 South America Pharmaceutical Grade CBD Oil Market Size by Country
10.3.1 South America Pharmaceutical Grade CBD Oil Sales in Volume by Country (2017-2028)
10.3.2 South America Pharmaceutical Grade CBD Oil Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pharmaceutical Grade CBD Oil Sales by Type (2017-2028)
11.2 Middle East & Africa Pharmaceutical Grade CBD Oil Sales by Application (2017-2028)
11.3 Middle East & Africa Pharmaceutical Grade CBD Oil Market Size by Country
11.3.1 Middle East & Africa Pharmaceutical Grade CBD Oil Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Pharmaceutical Grade CBD Oil Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Pharmaceutical Grade CBD Oil and Key Manufacturers
12.2 Manufacturing Costs Percentage of Pharmaceutical Grade CBD Oil
12.3 Pharmaceutical Grade CBD Oil Production Process
12.4 Pharmaceutical Grade CBD Oil Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Pharmaceutical Grade CBD Oil Typical Distributors
13.3 Pharmaceutical Grade CBD Oil Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 医薬品用CBDオイルの世界市場2022：フルスペクトラムCBDオイル、ブロードスペクトラムCBDオイル(Global Pharmaceutical Grade CBD Oil Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

医薬品用CBDオイルの世界市場2022：フルスペクトラムCBDオイル、ブロードスペクトラムCBDオイル

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp